Nicardipine Versus Labetalol During Intubation | NCT01041066 | Trialant
Unknown statusInterventionalNot ApplicableUpdated Dec 31, 2009
Nicardipine Versus Labetalol During Intubation
ClinicalTrials.gov ID
NCT01041066
Lead Sponsor
Seoul National University Bundang HospitalOTHER
Overall Status
Unknown status
Study Type
Interventional
Phase
Not Applicable
Enrollment
70Estimated
Last Update Posted
Dec 31, 2009Estimated
Start Date
Sep 2009
Primary Completion Date
Dec 2009Estimated
Brief Summary
The aim of this study was to compare the efficacy of nicardipine and labetalol in attenuation of cardiovascular responses to endotracheal intubation.
Patients Who Are Intubated for General Anesthesia
Endotracheal Intubation
labetalol
nicardipine
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients scheduled for general anesthesia with endotracheal intubation
Exclusion Criteria:
Patients with heart failure or coronary artery disease 2-3 degree atrio-ventricular block or severe bradycardia (< 45 beats/min) asthma, bronchial spasm or chronic obstructive pulmonary disease patients with anticipated difficult intubation (Mallampati class III, IV) severe hepatic or renal dysfunction allergy or contraindication to study medication
Primary Purpose
Prevention
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
Double
Jung-Hee Ryu, Ph.DContact
jinaryu@lycos.co.kr82-31-787-7497
Seoul National University Bundang HospitalRecruiting